Frequency of motor neuron diseases in a Mexico City referral center

Revista de Investigacion Clinica

Volumn 49, Issue 6, 1997, Pages 445-448

  Otero Siliceo, Enrique ^a,b   Arriada Mendicoa, Nicasio ^a   Corona Vázquez, Teresa ^a  

^a NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^b NONE   (Mexico)

Author keywords

Amyotrophic lateral sclerosis; Clinical characteristics; Increased frequency; Mexico; Motor neuron diseases; Young onset

Indexed keywords

ADULT; ARTICLE; FEMALE; HUMAN; INCIDENCE; MALE; MEXICO; MIDDLE AGED; MOTOR NEURON DISEASE; ONSET AGE; PATIENT REFERRAL; RETROSPECTIVE STUDY;

ADULT; AGE OF ONSET; FEMALE; HUMANS; INCIDENCE; MALE; MEXICO; MIDDLE AGED; MOTOR NEURON DISEASE; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES;

EID: 0031263883     PISSN: 00348376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Williams D, Windebank A. Motor neuron disease. Subject review. Mayo Clin Proc 1991; 66:54-73.
2. Swash M, Schwartz MS. What do we really know about amyotrophic lateral sclerosis. J Neurol Sci 1992; 113:4-16.
3. Mitsumoto H, Hanson MR, Chad DA. Amyotrophic Lateral Sclerosis. Recent advances in pathogenesis and therapeutics trials. Arch Neurol 1988; 45:189-99.
4. Caroscio J, Mulvihill M, Sterling R, Abrams B. Amyotrophic Lateral Sderosis. It's natural history. Neurologic Clinics 1987; 5:1-8.
5. Younger D, Chou S, Hays AP, Lange DJ, Emerson R, Brint M, et al. Primary Lateral Sclerosis. A clinical diagnosis reemerges. Arch Neurol 1988; 45:1304-7.
6. Chió A, Meinieri P, Tribolo A, Schiffer D. Risk factors in ALS. A case control study of ALS. Neuroepidemiology 1991; 10:174-8.
7. Durrleman S. Alperovitch A. Increasing trend of ALS in France and elsewhere. Are the changes real? Neurology 1989; 39:768-73.
8. Armon C, Kurland L, Daube JR, O'Brien PC. Epidemiology correlates of sporadic Amyotrophic Lateral Sclerosis. Neurology 1991; 41:1077-83.
9. The Scottish motor neuron disease research group. The Scottish MND. A prospective study of adult onset MND in Scotland. Methodology, demography and clinical features of incident cases in 1989. J Neurol Neurosurg Psychiat 1992; 55:536-41.
10. Giagheddu M, Mascia V, Cannas A, Pirastru MI, Sanna F, Rachele MG, et al. ALS in Sardinia Italy. An epidemiologic study. Acta Neurol Scand 1993; 87:446-54.
11. Kalfakis N, Vassilopoulos D. ALS in southern Greece. An epidemiologic study Neuroepidemiology 1991; 10:170-3.
12. Kahana E, Zilber N. Changes in the incidence of ALS in Israel. Arch Neurol 1984; 41:157-60.
13. Olivares A, San Esteban E, Alter M. Mexican "resistence" to Amyotrophic Lateral Sclerosis. Arch Neurol 1972; 27:397-402.
14. Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of Amyotrophic Lateral Sclerosis. J Neurol Sci 1994; 124(suppl):96-7.
15. Davidson TJ, Hartmann HA, Johnson PC. RNA content and volume of motor neurons in ALS I. The cervical swelling. J Neuropathol Exp Neurol 1981; 40:32-6.
16. Jablecki C, Berry C, Leach J. Survival predictions in ALS. Muscle Nerve 1989; 12:833-41.
17. Eisen A, Schulzer M, MacNeil M, Pant B, Mak E. Duration of ALS is age dependent. Muscle Nerve 1993; 16:27-32.
18. Christensen PB, Hojer-Pedersen E, Jensen NB. Survival of patients with Amyotrophic Lateral Sclerosis in 2 danish counties. Neurology 1990; 40:600-4.
19. Kristensen O, Melgaard B. Motor Neuron Disease. Prognosis and epidemiology. Acta Neurol Scand. 1977; 56:299-308.
20. Rosen AD. Amyotrophic Lateral Sclerosis. Clinical features and prognosis. Arch Neurol 1978; 35:638-42.
21. Gubbay SS, Kahana E, Zilber N, Cooper G, Pintov S, Leibowitz Y. Amyotrophic Lateral Sclerosis. A study of its presentation and prognosis. J Neurol 1985; 232:295-300.
22. Mortara P, Bardelli D, Leone M, Schiffer D. Prognosis and clinical varieties of ALS disease. Ital J Neurol Sci 1981; 2:237-42.
23. Annegers J, Appel S, Lee J, Perkins P. Incidence and prevalence of ALS in Harris County, Texas 1985-1988. Arch Neurol 1991; 48:589-93.